DK163126C - 1-ethyl-1,4-dihydro-4-oxo-3-carboxy-quinolin- eller -(1,8-naphthyridin)-derivater, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater indeholdende disse samt udgangsmateriale til brug ved fremgangsmaaden - Google Patents

1-ethyl-1,4-dihydro-4-oxo-3-carboxy-quinolin- eller -(1,8-naphthyridin)-derivater, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater indeholdende disse samt udgangsmateriale til brug ved fremgangsmaaden

Info

Publication number
DK163126C
DK163126C DK331384A DK331384A DK163126C DK 163126 C DK163126 C DK 163126C DK 331384 A DK331384 A DK 331384A DK 331384 A DK331384 A DK 331384A DK 163126 C DK163126 C DK 163126C
Authority
DK
Denmark
Prior art keywords
dihydro
ethyl
derivatives
naphthyridine
oxo
Prior art date
Application number
DK331384A
Other languages
Danish (da)
English (en)
Other versions
DK163126B (da
DK331384A (da
DK331384D0 (da
Inventor
Jose Esteve Soler
Original Assignee
Provesan Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8311250A external-priority patent/FR2548664B1/fr
Application filed by Provesan Sa filed Critical Provesan Sa
Publication of DK331384D0 publication Critical patent/DK331384D0/da
Publication of DK331384A publication Critical patent/DK331384A/da
Publication of DK163126B publication Critical patent/DK163126B/da
Application granted granted Critical
Publication of DK163126C publication Critical patent/DK163126C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK331384A 1983-07-06 1984-07-05 1-ethyl-1,4-dihydro-4-oxo-3-carboxy-quinolin- eller -(1,8-naphthyridin)-derivater, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater indeholdende disse samt udgangsmateriale til brug ved fremgangsmaaden DK163126C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR8311250A FR2548664B1 (fr) 1983-07-06 1983-07-06 Derives 7-(pyrrol-l-yl) des acides l-ethyl-1,4-dihydro-4-oxoquinoleine-3-carboxyliques et l-ethyl-1,4-dihydro-4-oxo-(1,8-naphtyridine)-3-carboxyliques substitues, leur preparation et leur application en tant que medicaments
FR8311250 1983-07-06
FR8402145 1984-02-13
FR8402145A FR2559484B2 (fr) 1983-07-06 1984-02-13 Nouveau derive 7-(pyrrol-1-yl) de l'acide 1-ethyl-1,4-dihydro-4-oxo-(1,8-naphtyridin)-3-carboxylique, sa preparation et son application en tant que medicament

Publications (4)

Publication Number Publication Date
DK331384D0 DK331384D0 (da) 1984-07-05
DK331384A DK331384A (da) 1985-01-07
DK163126B DK163126B (da) 1992-01-20
DK163126C true DK163126C (da) 1992-06-15

Family

ID=26223521

Family Applications (1)

Application Number Title Priority Date Filing Date
DK331384A DK163126C (da) 1983-07-06 1984-07-05 1-ethyl-1,4-dihydro-4-oxo-3-carboxy-quinolin- eller -(1,8-naphthyridin)-derivater, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater indeholdende disse samt udgangsmateriale til brug ved fremgangsmaaden

Country Status (21)

Country Link
US (1) US4552882A (es)
EP (1) EP0134165B1 (es)
KR (1) KR880002355B1 (es)
AT (1) ATE34982T1 (es)
AU (1) AU564326B2 (es)
BR (1) BR8403342A (es)
CA (1) CA1256876A (es)
CS (1) CS244139B2 (es)
DD (1) DD223150A5 (es)
DE (1) DE3471934D1 (es)
DK (1) DK163126C (es)
ES (1) ES8503335A1 (es)
FR (1) FR2559484B2 (es)
GR (1) GR81646B (es)
HK (1) HK10491A (es)
HU (1) HU189916B (es)
MX (1) MX156436A (es)
NO (1) NO163329C (es)
PL (1) PL143730B1 (es)
PT (1) PT78854B (es)
YU (1) YU43577B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2574404B1 (fr) * 1984-12-12 1987-04-24 Provesan Sa Derives 1-substitues de l'acide 6-fluoro-7-(pyrrol-1-yl)-1,4-dihydro-4-oxoquinoleine-3-carboxylique, leur preparation et leur application en tant que medicaments
DE3519286A1 (de) * 1985-05-30 1986-12-04 Bayer Ag, 5090 Leverkusen 7-azolyl-1-cyclopropyl-1,4-dihydro-4-oxo-3- chinolincarbonsaeuren und -1,8-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4692454A (en) * 1986-02-03 1987-09-08 Warner-Lambert Company Opthalmic use of quinolone antibiotics
DE3615767A1 (de) * 1986-05-10 1987-11-12 Bayer Ag Verfahren zur herstellung von 4-hydroxy-chinolin-3-carbonsaeuren
FR2607504B1 (fr) * 1986-12-02 1989-01-27 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent
US5262417A (en) * 1988-12-06 1993-11-16 The Upjohn Company Antibacterial quinolone compounds
ES2051225B1 (es) * 1992-07-23 1994-12-16 Esteve Quimica Sa Procedimiento de preparacion del acido 1-etil-6-fluoro-7-(pirrol-1-il) -1,4-dihidro-4-oxo-3-quinoleincarboxilico.
EP2147679B1 (en) 2001-07-25 2014-06-25 Raptor Pharmaceutical, Inc. Compositions for blood-brain barrier transport
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
DK2398500T3 (da) 2009-02-20 2019-05-13 2 Bbb Medicines B V Glutathion-baseret lægemiddelafgivelsessystem
IL255113B (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN104803975A (zh) * 2015-04-24 2015-07-29 河南大学 一种氨甲基三唑取代的二氟喹诺酮羧酸类衍生物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1006521A (en) * 1972-12-18 1977-03-08 Minoru Sugita Piperazine derivatives and process for preparing them
JPS5233694A (en) * 1975-09-09 1977-03-14 Dai Ichi Seiyaku Co Ltd Process for preparation of 6_nitro-1,8-naphthyridine derivatives
AR223983A1 (es) * 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico
JPS5649382A (en) * 1979-09-28 1981-05-02 Dainippon Pharmaceut Co Ltd 6-fluoro-7-cyclic amino-1,8-naphthylidine derivative and its salt

Also Published As

Publication number Publication date
BR8403342A (pt) 1985-06-18
YU119084A (en) 1986-12-31
NO163329C (no) 1990-05-09
YU43577B (en) 1989-08-31
ES533749A0 (es) 1985-03-01
NO842717L (no) 1985-01-07
DK163126B (da) 1992-01-20
HUT34482A (en) 1985-03-28
PT78854B (fr) 1986-10-23
CS528584A2 (en) 1985-08-31
FR2559484B2 (fr) 1986-09-26
GR81646B (es) 1984-12-11
DD223150A5 (de) 1985-06-05
FR2559484A2 (fr) 1985-08-16
AU2942584A (en) 1985-01-10
PL248545A1 (en) 1985-07-16
PL143730B1 (en) 1988-03-31
US4552882A (en) 1985-11-12
HU189916B (en) 1986-08-28
ATE34982T1 (de) 1988-06-15
KR850001198A (ko) 1985-03-16
EP0134165B1 (fr) 1988-06-08
NO163329B (no) 1990-01-29
DK331384A (da) 1985-01-07
EP0134165A3 (en) 1985-10-09
AU564326B2 (en) 1987-08-06
DE3471934D1 (en) 1988-07-14
EP0134165A2 (fr) 1985-03-13
KR880002355B1 (ko) 1988-10-29
MX156436A (es) 1988-08-22
ES8503335A1 (es) 1985-03-01
DK331384D0 (da) 1984-07-05
HK10491A (en) 1991-02-13
CA1256876A (en) 1989-07-04
PT78854A (fr) 1984-08-01
CS244139B2 (en) 1986-07-17

Similar Documents

Publication Publication Date Title
DK163126C (da) 1-ethyl-1,4-dihydro-4-oxo-3-carboxy-quinolin- eller -(1,8-naphthyridin)-derivater, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater indeholdende disse samt udgangsmateriale til brug ved fremgangsmaaden
HUT69407A (en) Process for producing quinolin-4-amine-and 1h-imidazo[4,5-c]quinolin-4-amine derivatives as intermediates
HUT43051A (en) Process for preparing pyridine-carboxylic acid derivatives and pharmaceutical compositions containing thereof as active ingredients
GR3019796T3 (en) Quinolone carboxylic acid derivatives, process for their preparation and their use
NZ214746A (en) 1-cyclopropyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid derivatives and pharmaceutical compositions
ATE89561T1 (de) 3,4-disubstituierte-2-azetidinon-derivate und verfahren zu ihrer herstellung.
ES2004255A6 (es) Procedimiento de preparar compuestos del tipo de las piracinas y analogos.

Legal Events

Date Code Title Description
PBP Patent lapsed